Official AMFI data
Arthkar — Understand Money, Invest Smartly

Listed equity

Dr Agarwal'S Eye Hospital

डॉ अग्रवाल्स आई · ડો.અગ્રવાલ આઇ

BSE: 526783M-cap ₹2.4K Cr2 mutual funds hold this
₹5082.60▲₹56.20(+1.10%)

EOD close · 1 Oct 2026

consolidationneutral +19Quiet accumulation · 1d

Range-bound — awaiting direction.

52W low ₹4412.0552W high ₹6392.00

Now at 34% of its 52-week range

Last 30 sessions

-3.7%

Phase indicator

consolidation-20.5% from 52w high

Range-bound — awaiting direction.

1M
-2.0%
3M
+3.0%
1Y
+4.3%

Delivery conviction

neutralscore +19
Delivery vs 20-day avg1.07x
Buy / sell pressure85.5% buy
Quiet accumulation active for 1 consecutive day. See full screener

Lifetime story

Dr Agarwal'S Eye Hospital is up 96711.4% from its lifetime low of ₹5.25 on 4 Mar 2002. ₹10,000 invested then would be worth ₹96,81,143 today (32.3% CAGR over 24.6 years). Lifetime high of ₹7300.00 was set on 3 Jan 2025 (currently -30.4% below).

30-day conviction trend

17 Aug 20261 Oct 2026

Fundamentals

Standalone vs consolidated — most retail products show only one. Consolidated includes subsidiary contribution.

66% cheaper than industry(Industry P/E 95.2)
StandaloneConsolidated
P/E (TTM)subs material31.940.00
P/B6.59—
Price / Cash flowsubs material19.980.00
Dividend yield0.14%0.14%
Book value / share786.28 ₹—
EPS (TTM)subs material162.17 ₹0.00 ₹
Market cap
₹2.4K Cr
52W high
₹6392.00
2 Jan 2026
52W low
₹4412.05
30 Jan 2026

Returns ladder

1W
+0.1%
1M
-2.0%
3M
+3.0%
6M
+10.2%
YTD
-2.9%
1Y
+4.3%
3Y
+118.2%
5Y
+1201.0%
10Y
+2745.4%
Since listing
+10000.0%

How this page is produced

Every figure above is computed from end-of-day exchange prices, snapshotted daily, closing 1 Oct 2026. Nothing here is copied from a factsheet or a third-party summary. The full method is published, including its limitations.

Prices are end-of-day closes, not live quotes, and are not intended for trading decisions.

Written and maintained by Azad Mohammed, who built the pipeline these numbers come out of. Found an error? Tell us — corrections are made and the page rebuilds within the hour.

This page describes what has already happened. It is not investment advice and not a recommendation to buy or sell any security. Arthkar is not a SEBI-registered investment adviser or research analyst, and does not provide or arrange investment advice. Investments in securities are subject to market risk.